hsa-miR-29c* Is Linked to the Prognosis of Malignant Pleural Mesothelioma
Harvey I. Pass(NYU Langone Health), Ranit Aharonov(Unknown), Michele Carbone(Cancer Center of Hawaii), Sergey V. Ivanov(Bellevue Hospital Center), Chandra Goparaju(New York University), Ayelet Chajut(Rosetta Genomics (Israel)), Harel Dan(University of Hawaiʻi at Mānoa), Moshe Hoshen(University of Hawaiʻi at Mānoa), Sima Benjamin(University of Hawaiʻi at Mānoa), Shai Rosenwald(Rosetta Genomics (Israel)), Dalia Cohen(Regulus Therapeutics (United States)), Jessica Donington(New York Harbor School)
Cited by 148
Related Papers
MicroRNAs accurately identify cancer tissue origin
|Nature Biotechnology|2008|987
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
|Cancer Discovery|2018|630
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
|Journal of Clinical Oncology|2009|410
Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects
|Journal of Biological Chemistry|1999|393
Design of a genome-wide siRNA library using an artificial neural network
|Nature Biotechnology|2005|386